⚡ Key Takeaways

More than 10 US states have enacted or advanced legislation mandating human clinical review before health insurers can deny claims using AI. California, Arizona, Nebraska, and Maryland led the 2025 wave, while Georgia, Minnesota, and others are advancing bills in 2026. In the 2025 session alone, 47 states introduced over 250 healthcare AI bills, with 33 signed into law.

Bottom Line: Organizations developing AI-driven healthcare decision systems must design for human-in-the-loop review from the start, as the US regulatory template will likely influence global standards within 18 months.

Read Full Analysis ↓

Advertisement

🧭 Decision Radar

Relevance for Algeria
Medium

Algeria’s CNAS and Caisse de Securite Sociale have not yet deployed AI for claims processing, but the global debate establishes regulatory precedents that will inform future Algerian digital health governance frameworks.
Infrastructure Ready?
No

Algeria’s health insurance systems remain largely paper-based and manual. AI-driven claims processing is not yet technically feasible at scale in the current infrastructure.
Skills Available?
Limited

Few Algerian health insurers or regulators have the technical expertise to implement or oversee AI-based claims review systems, though medical informatics programs are emerging.
Action Timeline
12-24 months

The regulatory models being established in the US will take 1-2 years to crystallize into exportable frameworks that Algeria might reference for digital health modernization.
Key Stakeholders
Health ministry officials,
Decision Type
Educational

This article provides foundational knowledge about an emerging regulatory paradigm that will shape global health-tech governance for years to come.

Quick Take: Algerian healthcare regulators should study the US state-level approach as a template for future AI governance. As Algeria’s CNAS modernization plans advance, building human-review requirements into the design phase is far cheaper than retrofitting them later. Health informatics programs at Algerian universities should incorporate AI ethics and clinical decision-support governance into their curricula now.

The Bipartisan Revolt Against Algorithmic Denials

A rare point of bipartisan agreement is reshaping American health insurance: legislators from red and blue states alike are telling insurers they cannot use artificial intelligence as the sole basis for denying medical claims. As of April 2026, more than ten states have either enacted laws or advanced legislation mandating that a licensed physician must review any AI-driven coverage denial before it reaches a patient.

The movement was triggered by high-profile controversies. UnitedHealth Group’s nH Predict algorithm and Cigna’s automated denial systems drew national attention when investigations revealed that AI tools were rejecting claims at industrial scale with minimal or no physician oversight. Patients with serious conditions found their coverage denied by algorithms that never reviewed their medical records.

What the Laws Actually Require

The enacted statutes share a common architecture: AI can assist in claims processing, but a qualified human clinician must make the final determination on any denial.

California led the charge with SB 1120, the Physicians Make Decisions Act, effective January 1, 2025. The law prohibits any denial, delay, or modification of care based on medical necessity unless reviewed and decided by a licensed physician with expertise in the relevant clinical area.

Arizona followed with a law effective July 1, 2026, requiring a licensed Arizona physician to personally review and sign off on any AI-based denial of claims or prior authorizations involving medical necessity.

Nebraska’s LB 77 prohibits AI output from being the sole basis for evaluating medical necessity to deny, delay, or modify healthcare services. Maryland’s HB 820 adds an audit dimension, requiring that AI tools used for utilization review incorporate individual medical history and remain open for state inspection.

Utah, Connecticut, and Texas have enacted comparable restrictions, with Texas requiring written disclosure to patients when AI is used in connection with healthcare services, effective January 1, 2026.

Advertisement

The 2026 Legislative Wave

The momentum is accelerating. Georgia’s SB 444 passed the Senate and requires human clinical review before insurers deny doctor-ordered care. Minnesota is advancing a bill specifically targeting AI denials of prior authorization requests. Kansas, Pennsylvania, and several other states have introduced similar measures in their 2026 sessions.

The numbers tell a striking story: 47 states introduced more than 250 healthcare AI bills during the 2025 legislative session alone, with 33 signed into law across 21 states.

Federal vs. State Tension

What makes this wave particularly significant is the emerging tension with the federal government. The White House has signaled disagreement with the state-level approach, favoring industry self-regulation and lighter-touch federal guidelines. This creates a potential preemption battle that could define the future of AI governance in healthcare.

Insurance industry groups argue that AI improves efficiency, reduces processing times, and can catch fraud more effectively than manual review. They warn that mandating human review for every denial could slow claims processing and increase administrative costs. However, patient advocacy organizations counter that speed cannot come at the cost of accuracy when lives are at stake.

The Compliance Challenge for Insurers

For health insurers operating across multiple states, the emerging patchwork of laws creates significant compliance complexity. Each state defines “human review” slightly differently — California requires a physician with relevant clinical expertise, Arizona mandates a licensed state physician, and Maryland focuses on audit transparency. Insurers must now map their AI claims workflows against at least ten distinct regulatory frameworks, with more coming online quarterly.

The practical impact is forcing insurers to redesign their AI-assisted claims pipelines. Rather than eliminating AI entirely, most are building hybrid workflows where algorithms flag potential denials but licensed clinicians make the final call. This “AI-assisted, human-decided” model is emerging as the de facto compliance standard.

Follow AlgeriaTech on LinkedIn for professional tech analysis Follow on LinkedIn
Follow @AlgeriaTechNews on X for daily tech insights Follow on X

Advertisement

Frequently Asked Questions

What exactly do these state laws require from health insurers?

The laws mandate that health insurers cannot use AI algorithms as the sole basis for denying medical claims or prior authorization requests. A licensed physician or qualified healthcare provider must personally review the patient’s medical records and make the final determination. States like California require the reviewing physician to have expertise in the specific clinical area at issue.

Why are both Republican and Democratic states supporting these regulations?

AI-driven claim denials affect patients across the political spectrum. Investigations into algorithms like UnitedHealth’s nH Predict revealed that AI tools were denying claims at industrial scale without reviewing individual medical records. The human impact of algorithmic denials — delayed cancer treatments, denied surgical approvals — creates bipartisan urgency that transcends typical partisan divides on regulation.

How are health insurers adapting to comply with multiple state laws?

Most insurers are building hybrid “AI-assisted, human-decided” workflows where algorithms flag potential denials but licensed clinicians make the final call. The compliance challenge is significant: each state defines human review differently, forcing insurers to map their AI claims pipelines against at least ten distinct regulatory frameworks. Many are investing in clinical reviewer staffing and state-by-state compliance tracking systems.

Sources & Further Reading